| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |